Andreas K. Klein

1.7k total citations
54 papers, 731 citations indexed

About

Andreas K. Klein is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Andreas K. Klein has authored 54 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 21 papers in Hematology and 17 papers in Oncology. Recurrent topics in Andreas K. Klein's work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Multiple Myeloma Research and Treatments (10 papers). Andreas K. Klein is often cited by papers focused on Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Multiple Myeloma Research and Treatments (10 papers). Andreas K. Klein collaborates with scholars based in United States, Australia and Germany. Andreas K. Klein's co-authors include Kellie Sprague, Geoffrey Chan, Francine M. Foss, Andrew M. Evens, K B Miller, Kirk A. Stiffler, Howard Grodman, Kevin M. Chin, Kenneth B. Miller and Jane N. Winter and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andreas K. Klein

51 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas K. Klein United States	15	350	271	200	177	114	54	731
Francesco Gaudio Italy	13	270 0.8×	201 0.7×	349 1.7×	204 1.2×	102 0.9×	53	676
Stephanie Gregory United States	13	379 1.1×	331 1.2×	331 1.7×	134 0.8×	174 1.5×	26	963
G. J. Ossenkoppele Netherlands	18	308 0.9×	309 1.1×	269 1.3×	218 1.2×	164 1.4×	51	832
Roberto Sorasio Italy	14	291 0.8×	542 2.0×	210 1.1×	108 0.6×	286 2.5×	33	853
Chun‐Hsin Wu Taiwan	9	360 1.0×	159 0.6×	137 0.7×	123 0.7×	161 1.4×	21	686
Henry Januszewicz Australia	15	191 0.5×	126 0.5×	356 1.8×	108 0.6×	115 1.0×	23	644
Jean‐Marc Schiano de Colella France	13	261 0.7×	145 0.5×	263 1.3×	194 1.1×	62 0.5×	41	600
Piero Farruggia Italy	20	223 0.6×	207 0.8×	113 0.6×	222 1.3×	234 2.1×	62	889
Eulogio Conde Spain	15	408 1.2×	186 0.7×	534 2.7×	177 1.0×	148 1.3×	43	869
Rose Beck United States	14	262 0.7×	172 0.6×	188 0.9×	266 1.5×	149 1.3×	49	699

Countries citing papers authored by Andreas K. Klein

Since Specialization

Citations

This map shows the geographic impact of Andreas K. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas K. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas K. Klein more than expected).

Fields of papers citing papers by Andreas K. Klein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas K. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas K. Klein. The network helps show where Andreas K. Klein may publish in the future.

Co-authorship network of co-authors of Andreas K. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas K. Klein. A scholar is included among the top collaborators of Andreas K. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas K. Klein. Andreas K. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mico, Vasil, et al.. (2025). Teclistamab in relapsed/refractory systemic AL amyloidosis.. Journal of Clinical Oncology. 43(16_suppl). 7562–7562.

Gergis, Usama, Aaron J. Martin, A. Vogel, et al.. (2024). PBCAR19B, an Immune Evading Allogeneic CAR T Stealth Cell, Demonstrates Potent Anti-Tumor Responses and Prolonged B Cell Depletion Supporting Sustained Immune Evasion in Patients with Relapsed/Refractory (R/R) B-Cell Lymphoma (NHL). Blood. 144(Supplement 1). 7175–7175. 1 indexed citations

Topp, Max S., Monika Długosz‐Danecka, Aleksander B. Skotnicki, et al.. (2023). Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies. Trials. 24(1). 9 indexed citations

Markman, Kris M., et al.. (2022). Developing an engaging and accessible clinical research training program for new investigators. Journal of Clinical and Translational Science. 7(1). e53–e53. 1 indexed citations

Gregory, Gareth P., Shaji Kumar, Ding Wang, et al.. (2021). Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study. Blood Advances. 6(4). 1232–1242. 24 indexed citations

Godara, Amandeep, et al.. (2021). Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFα-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure. SHILAP Revista de lepidopterología. 5(1). e146–e146. 22 indexed citations

Evens, Andrew M., Ranjana H. Advani, Irene Helenowski, et al.. (2018). Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma. Journal of Clinical Oncology. 36(30). 3015–3022. 96 indexed citations

Murray, Peter D., Barbara E. Bierer, Steven Hirschfeld, Andreas K. Klein, & Jonathan M. Davis. (2018). Assessment of a shortened informed consent form for pediatric research: a pilot study. Pediatric Research. 84(4). 516–519. 5 indexed citations

Chaulagain, Chakra P., Kellie Sprague, Monika Pilichowska, et al.. (2018). Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Bone Marrow Transplantation. 54(4). 560–566. 8 indexed citations

10.

Rosenberg, Aaron S., Robin Ruthazer, Jessica K. Paulus, et al.. (2016). Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders. Clinical Lymphoma Myeloma & Leukemia. 16(12). 684–692.e3. 13 indexed citations

11.

Jurdi, Najla El, Mark S. Bankoff, Andreas K. Klein, & Muhammad Wasif Saif. (2016). Perforation of the Colon During Imatinib Mesylate (Gleevec) Treatment in a Patient with Chronic Myeloid Leukemia (CML). Cureus. 8(6). e660–e660. 5 indexed citations

12.

Shah, Gunjan L., Aaron N. Winn, Pei‐Jung Lin, et al.. (2015). Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results–Medicare Database. Biology of Blood and Marrow Transplantation. 21(10). 1823–1829. 24 indexed citations

13.

Chaulagain, Chakra P., Xun Ma, Parul Doshi, et al.. (2015). Pre-clinical translational studies of daratumumab in patients with myeloma or AL amyloidosis undergoing autologous hematopoietic stem cell transplantation (SCT).. Journal of Clinical Oncology. 33(15_suppl). 8587–8587. 2 indexed citations

14.

Rosenberg, Aaron S., Gunjan L. Shah, Raymond L. Comenzo, et al.. (2014). Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis. Blood. 124(21). 3170–3170. 5 indexed citations

15.

Shah, Gunjan L., Hedy Smith, Kellie Sprague, et al.. (2013). Bortezomib Subcutaneous Injection in Combination Regimens for Myeloma or Systemic Light-Chain Amyloidosis: A Retrospective Chart Review of Response Rates and Toxicity in Newly Diagnosed Patients. Clinical Therapeutics. 35(10). 1614–1620. 15 indexed citations

16.

Klein, Andreas K., K B Miller, Kellie Sprague, Jeffrey A. DesJardin, & David R. Snydman. (2010). A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT. Bone Marrow Transplantation. 46(2). 294–299. 22 indexed citations

17.

Betancur, Monica, et al.. (2009). Variable Contribution of Monoclonal Antibodies to ADCC in patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 50(8). 1361–1368. 21 indexed citations

18.

Kovalszki, Anna, et al.. (2008). Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplantation. 41(11). 965–969. 48 indexed citations

19.

Pilichowska, Monika, et al.. (2007). A 64-Year-Old Woman With Cough and Right Middle Lobe Collapse. CHEST Journal. 132(5). 1691–1696. 2 indexed citations

20.

Foss, Francine M., Kevin M. Chin, Kellie Sprague, et al.. (2005). Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplantation. 35(12). 1187–1193. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact